Utilization of fine-needle aspiration in the diagnosis of metastatic tumors to the kidney

Citation
P. Gattuso et al., Utilization of fine-needle aspiration in the diagnosis of metastatic tumors to the kidney, DIAGN CYTOP, 21(1), 1999, pp. 35-38
Citations number
25
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology
Journal title
DIAGNOSTIC CYTOPATHOLOGY
ISSN journal
87551039 → ACNP
Volume
21
Issue
1
Year of publication
1999
Pages
35 - 38
Database
ISI
SICI code
8755-1039(199907)21:1<35:UOFAIT>2.0.ZU;2-M
Abstract
Renal masses secondary to metastases are not common. Few comprehensive revi ews exist, which consist primarily of autopsy and radiologic reports. The p urpose of this study was to review the types and incidences of various neop lasms which metastasize to the kidney and to determine the usefulness of fi ne-needle aspiration (FNA) in diagnosing them. Two hundred and sixty-one ra diologically guided FNAs of renal lesions over a 9-yr period were reviewed The diagnoses of the 261 renal FNAs were as follows: 136 (52%) were maligna nt, 111 (43%) were benign, and 14 (5%) were unsatisfactory. Of the 136 posi tive FNAs, 28 (21%) revealed metastatic hrmora. The overall incidence of re nal FNAs displaying metastatic tumors was 11 %. Among the 28 patients with metastases to the kidney, 23 patients were men and 5 were women, with the m ean age being 58 yr: Twenty-five patients (89%) had prior history of a prim ary malignancy, including lung carcinoma (11 cases, 39%), lymphoma (8 cases , 29%), hepatocellular carcinoma (3 cases, 11%), and one case each of breas t, pancreatic, and cervical cancer In the remaining 3 patients (11%), with metastatic adenocarcinoma (2 cases) and squamous-cell carcinoma (I case), t he primary tumor site remained unknown despite an extensive clinical workup . Overall survival after FNA was pool; with a mean of 9.8 Ino. FNA is usefu l in the diagnosis of masses in the kidney secondary to metastatic disease. This information is of clinical importance, principally in the exclusion o f a primary malignancy, but also to avoid unnecessary surgery and to plan f or subsequent patient care. (C) 1999 WiIey-Liss, Inc.